Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
Year: 1992
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: S Vadhan-Raj, H E Broxmeyer, W N Hittelman, N E Papadopoulos, S P Chawla, C Fenoglio, S Cooper, E S Buescher, R W Frenck, A Holian
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2143098122
